Please join us on Monday, March 14, 2022 at 12:00 pm, where we will discuss the concept of Analogous Prior Art in Obviousness rejections, as well as delve into the issues in the Moderna-NIH conflict over Covid vaccine patent rights. Please see Analogous Prior Art slides here. Please see Moderna-NIH slides here, and patent filing [...]
Our weekly SoCal IP Institute meeting on Monday, May 10, 2021 will be a discussion of two Federal Circuit cases: Functional Claim “Raises the Bar for Enablement” In Amgen v. Sanofi and Regeneron (Fed. Cir. 2021) (available - Amgen case) the CAFC provided another anti-functional-limitation decision — this time rendering Amgen’s monoclonal antibody claims invalid. [...]
We will be discussing two Federal Circuit cases during our weekly SoCal IP Institute meeting on Monday, June 25, 2012. Brief synopses are presented below. Bard Peripheral v. W.L. Gore, Case No. 2010-1510 (Fed. Cir. June 14, 2012) (attached). The District Court for the District of Arizona had previously held that Gore had willfully infringed [...]
We will be discussing one case involving prior invention and another involving standing to bring a patent case during our weekly SoCal IP Institute meeting on Monday, December 5, 2011. Brief synopses are presented below. Teva Pharma. Indus. Ltd. v. Astrazeneca Pharma. LP, Case No. 2011-1091 (Fed. Cir. Dec. 1, 2011) (attached). Teva sued Astrazeneca [...]